Ensign Peak Advisors Inc Invests $882,000 in Solventum Co. (NYSE:SOLV)

Ensign Peak Advisors Inc acquired a new position in Solventum Co. (NYSE:SOLVFree Report) in the 2nd quarter, HoldingsChannel reports. The firm acquired 16,686 shares of the company’s stock, valued at approximately $882,000.

Several other institutional investors also recently modified their holdings of the business. Deseret Mutual Benefit Administrators bought a new stake in Solventum during the second quarter worth $25,000. Hollencrest Capital Management purchased a new stake in shares of Solventum during the 2nd quarter valued at $25,000. Partnership Wealth Management LLC bought a new stake in shares of Solventum during the 2nd quarter worth $26,000. Richard W. Paul & Associates LLC purchased a new position in shares of Solventum in the 2nd quarter worth about $26,000. Finally, Family Firm Inc. bought a new position in Solventum during the second quarter valued at about $26,000.

Wall Street Analyst Weigh In

Several analysts have commented on SOLV shares. Wells Fargo & Company lowered their price objective on shares of Solventum from $69.00 to $64.00 and set an “equal weight” rating on the stock in a research report on Friday, August 9th. Bank of America dropped their price objective on Solventum from $70.00 to $60.00 and set a “neutral” rating on the stock in a research note on Tuesday, June 25th. Argus started coverage on Solventum in a research report on Monday, June 24th. They issued a “hold” rating for the company. Wolfe Research started coverage on Solventum in a research note on Thursday. They set a “peer perform” rating for the company. Finally, Morgan Stanley cut their price target on Solventum from $70.00 to $55.00 and set an “equal weight” rating for the company in a research note on Monday, July 15th. One equities research analyst has rated the stock with a sell rating and seven have issued a hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $58.25.

Get Our Latest Report on SOLV

Solventum Trading Down 0.8 %

SOLV stock opened at $67.57 on Friday. The company has a quick ratio of 0.96, a current ratio of 1.31 and a debt-to-equity ratio of 2.90. Solventum Co. has a fifty-two week low of $47.16 and a fifty-two week high of $96.05. The business’s fifty day moving average price is $62.70.

Solventum (NYSE:SOLVGet Free Report) last issued its quarterly earnings data on Thursday, August 8th. The company reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.46 by $0.10. The company had revenue of $2.08 billion for the quarter, compared to analysts’ expectations of $2.05 billion. Solventum’s revenue for the quarter was up .2% on a year-over-year basis. Analysts anticipate that Solventum Co. will post 6.38 earnings per share for the current fiscal year.

About Solventum

(Free Report)

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

Featured Articles

Want to see what other hedge funds are holding SOLV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Solventum Co. (NYSE:SOLVFree Report).

Institutional Ownership by Quarter for Solventum (NYSE:SOLV)

Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.